福泰制药计划三月底前完成Povetacicept的BLA提交 寻求美国加速批准

美股速递
Mar 10

福泰制药(Vertex Pharmaceuticals)宣布,计划于三月底前完成其在研药物Povetacicept的生物制品许可申请(BLA)提交工作。此举旨在为这款候选药物在美国市场争取加速批准资格。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10